A permanent human cell line, EA hy 926, has been established that expresses at least one highly differentiated function of vascular endothelium, factor VII-related antigen. This line was derived by fusing human umbilical vein endothelial cells with the permanent human cell, line A549. Hybrid cells that survived in selective medium had more chromosomes than either progenitor cell type and included, a marker. chromosome from the A549 line. Factor VIII-related antigen can be identified intracellularly in the hybrids by immunofluorescence and accumulates in the culture fluid. Expression of factor VIH-related antigen by these hybrid cells has been maintained for more than 100 cumulative population doublings, including more than 50 passages and three cloning steps. This is evidence that EA-hy 926 represents a permanent line.Differentiated functions of endothelium are critical for the vascularization process in normal and neoplastic tissue, for maintaining the blood-brain barrier, and for hemostasis. Factor VIIIrelated antigen (VIIIR:Ag) is an endothelial cell product (1) involved in the aggregation of platelets, and megakaryocytes are the only other cell type known to express this antigen (2).VIIIR:Ag is present in normal human plasma at about 10 pug/ ml, and decreased levels are found in classical von Willebrand disease, an autosomal dominantly inherited bleeding disorder in humans. VIIIR:Ag circulates as a large molecular complex and its platelet-aggregating activity is directly related to the size distribution of the complex (3). Factor VIII coagulant activity (antihemophilic factor) is also associated with the VIIIR:Ag complex in plasma. We have previously described interspecies hybrids between human endothelial cells and a number of rodent cell lines, in which VIIR:Ag was not expressed (7). There has also been a preliminary report by others (8) of human-rodent hybrids that may express VIIIR:Ag, but the intracellular distribution of antigenicity that they detect is not similar to that of VIIIR:Ag in endothelial cells.Here we report a human intraspecies hybrid, EA-hy 926, that expresses VIIIR:Ag with the same morphological distribution as in primary endothelial cells. MATERIALS AND METHODSCell Culture. Cells were cultured on plastic ware at 370C in a humid atmosphere containing 7% CO2 in air. Culture medium was exchanged every 3-5 days. At confluence, 0.01% trypsin (TRL Worthington, no. LSOO 044 52) in 8 mM phosphate-buffered saline (pH 7.4) with 0.54 mM EDTA and 5.5 mM glucose was used to detach the cells, which were then subcultured at lower cell density.Human umbilical vein endothelial cells (HUV-EC) were isolated as described in detail by Gimbrone (9). The vein of an umbilical cord kept at 40C for 4 hr postpartum was irrigated with phosphate-buffered saline. The endothelial cells were dissociated from the vessel wall with 0.1% collagenase (Sigma, no. C2139) in phosphate-buffered saline at 370C for 20 min. The cells were separated from the collagenase solution by centrifugation and were distributed over...
Objective:Evaluate the experience of paramedic personnel at mass gatherings in the absence of on-site physicians.Design:Retrospective review of patients evaluated by paramedics with emergency medical services (EMS) medical control.Setting:First-aid facility operated by paramedics at an outdoor amphitheater involving 32 (predominantly rock music) concerts in accordance with the Chicago EMS System, June through September 1990.Participants:A total of 438 patients (≤0.1% on-site population) were evaluated.Interventions:Presentations to the first-aid facility were viewed as if the patient was presenting to an ambulance. Transportation to an emergency department was strongly recommended for all encounters. Time from presentation to the first-aid facility until disposition was limited to 30 minutes in the absence of on-line [direct] medical control. Refusal of care was accepted. On-line [direct] medical control with the EMS resource hospital was initiated as needed. Off-line [indirect] medical control consisted of weekly reviews of all patient records and periodic site visits.Results:Of the 438 patients, 366 (84%) refused further care, including 31 patients (7%) who refused advanced life support (ALS) level care. Seventy-two patients (16%) were transported; 37 by ALS and 35 by basic life support (BLS) units. On-line [direct] medical control was initiated in all ALS patients that were transported as well as for those who refused care. No known deaths or adverse outcomes occurred, based on lack of inquiries or complaints from the local EMS system, emergency departments receiving transported patients, law enforcement agencies, 9-1-1 emergency response providers, venue management, or security. No request for medical records from law firms have occurred. Problems noted initially were poor documentation and a tendency not to document all encounters (e.g., dispensing band-aids, tampons, earplugs, etc.). Concerns noted included: initial and subsequent vital signs, times of arrival, interventions, dispositions, and patient conditions of refusal. Specific problems with documentation of refusals at disposition included: appropriate mental status, speech, and gait; release with an accompanying family member or friend; and parental notification and approval of care for minors. There also was an initial tendency not to establish on-line [direct] medical control for ALS refusal or BLS medicolegal issues.Conclusions:The medical system configuration modeled after practices of prehospital care, demonstrates physicians did not need to be onsite when adequate EMS medical control existed with less than 30 minutes on-scene time.
This trend suggests that use of paralytic drugs by paramedics is becoming standard of care in many out-of-hospital systems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.